DaxibotulinumtoxinA for Blepharospasm
DaxibotulinumtoxinA for Blepharospasm
Recruiting · NCT07489430 · Registry updated 2026-09-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| DaxibotulinumtoxinA for Blepharospasm | Dyskinesias, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, basal ganglia disorder, benign essential blepharospasm, brain disorder, central nervous system disorder, dystonic disorder, eye disorder, eyelid disorder, movement disorder, nervous system disorder, parkinsonian disorder | Recruiting | Phase 2 | 2026-09-29 | NCT07489430 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Revance Therapeutics, Inc. | 2 |
| University of Pennsylvania | 502 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Parkinson Disease and Movement Disorders Center at the University of Pennsylvania | Philadelphia | United States | 1 |